Winton Group’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-18,598
Closed -$705K 791
2024
Q3
$705K Sell
18,598
-1,065
-5% -$43.8K 0.05% 384
2024
Q2
$890K Buy
+19,663
New +$905K 0.06% 338
2023
Q2
Sell
-26,950
Closed -$1.7M 1122
2023
Q1
$1.7M Buy
26,950
+12,549
+87% +$749K 0.1% 254
2022
Q4
$766K Sell
14,401
-5,710
-28% -$309K 0.05% 497
2022
Q3
$1.13M Sell
20,111
-23,508
-54% -$1.55M 0.07% 372
2022
Q2
$3.16M Buy
43,619
+6,607
+18% +$492K 0.17% 152
2022
Q1
$2.94M Buy
37,012
+7,161
+24% +$646K 0.15% 142
2021
Q4
$3.02M Buy
29,851
+6,836
+30% +$682K 0.18% 106
2021
Q3
$2.12M Sell
23,015
-2,343
-9% -$225K 0.12% 168
2021
Q2
$2.6M Buy
25,358
+2,088
+9% +$210K 0.14% 102
2021
Q1
$2.27M Buy
23,270
+788
+4% +$71.7K 0.13% 109
2020
Q4
$1.73M Sell
22,482
-32,219
-59% -$2.49M 0.13% 158
2020
Q3
$4.03M Buy
54,701
+1,311
+2% +$105K 0.13% 205
2020
Q2
$3.92M Buy
53,390
+4,473
+9% +$351K 0.1% 322
2020
Q1
$2.83M Sell
48,917
-6,305
-11% -$439K 0.07% 456
2019
Q4
$4.34M Buy
+55,222
New +$4.07M 0.06% 524
2019
Q3
Sell
-10,505
Closed -$834K 1696
2019
Q2
$834K Buy
10,505
+3,077
+41% +$244K 0.02% 473
2019
Q1
$623K Sell
7,428
-1,483
-17% -$155K 0.01% 491
2018
Q4
$1.05M Sell
8,911
-1,636
-16% -$189K 0.02% 340
2018
Q3
$1.27M Buy
10,547
+2,122
+25% +$263K 0.03% 361
2018
Q2
$971K Buy
8,425
+733
+10% +$80.2K 0.02% 440
2018
Q1
$661K Buy
+7,692
New +$596K 0.02% 661

Other funds holding USNA

Winton Group's USNA Position: Q4 2024 in Review

Winton Group sold out of Usana Health Sciences (USNA) in Q4 2024, closing a stake of 18,598 shares — an estimated $705K sold.

Winton Group first reported a position in USNA in Q1 2018 and held it in 22 quarters. The position peaked at $4.34M in Q4 2019. 152 funds tracked by Wall St. Rank hold USNA as of Q4 2024.

  • Winton Group reported no remaining Usana Health Sciences position as of Q4 2024 after selling out during the quarter.
  • Winton Group sold 18,598 Usana Health Sciences shares in Q4 2024, an estimated $705K.
  • Winton Group first reported a position in Usana Health Sciences in Q1 2018 and held it in 22 quarters.
  • Winton Group's Usana Health Sciences position peaked at $4.34M in Q4 2019.
  • 152 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2024.

Based on Winton Group's 13F filing for Q4 2024, filed 12 Feb 2025.